History
  • No items yet
midpage
Pfizer, Inc. v. Lee
811 F.3d 466
Fed. Cir.
2016
Read the full case

Background

  • Wyeth filed U.S. Patent Application No. 10/428,894 (later U.S. Patent No. 8,153,768) in May 2003; patent issued April 10, 2012.
  • Patent Term Adjustment (PTA) under 35 U.S.C. § 154(b) awards A-, B-, and C-Delays to compensate PTO-caused prosecution delays; A-Delay stops when the PTO "provides at least one of the notifications under section 132."
  • PTO issued a restriction requirement on August 10, 2005 (404 days past the 14‑month deadline). The restriction described 21 invention groups but omitted classification of six dependent claims.
  • Wyeth contacted the examiner; the examiner withdrew the flawed restriction and issued a corrected restriction on February 23, 2006 (197 days later). PTO awarded PTA but excluded those 197 days from A-Delay.
  • Wyeth/Pfizer sued under 35 U.S.C. § 154(b)(4), seeking inclusion of the 197 days as A-Delay; district court granted summary judgment to the PTO. The Federal Circuit affirmed (majority) with one dissent.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether the PTO must count the 197‑day period between the initial, incomplete restriction requirement and the corrected restriction requirement as A‑Delay under § 154(b)(1)(A) The initial restriction was defective under § 132 (omitted classifications), so it did not "provide" the required notification and A‑Delay continued until the corrected notice; PTO error caused the delay The initial restriction satisfied § 132 because it identified the broad statutory basis and defined the 21 invention groups (unchanged in the correction), so the A‑Delay clock stopped when the initial restriction was mailed Court held the initial restriction met § 132’s notice requirement; the 197 days were not PTO A‑Delay, so summary judgment for the PTO affirmed
Whether Appellants waived the § 132 notice argument by failing to raise it below Appellants had sufficiently raised § 132 arguments in briefing and oral argument PTO argued waiver Court found no waiver; argument was preserved
Whether Chester v. Miller controls (i.e., whether an imprecise office action can still satisfy § 132) Chester supports finding the initial restriction insufficient because it omitted claim classifications PTO relied on Chester to show § 132 requires only that applicant be informed of the broad statutory basis and issues to respond to Court applied Chester: initial restriction gave sufficient notice of the statutory basis and issues, so § 132 satisfied
Whether MPEP or § 121 safe‑harbor concerns change the result (consonance / patentability consequences) Omission undermines the § 121 safe‑harbor and consonance; a complete restriction is required to preserve rights Examiner’s grouping descriptions were unchanged and applicants could have replied and preserve rights; making the restriction final occurred after applicant response and examiner action Court held § 121/safe‑harbor concerns did not make the initial restriction invalid for § 132 purposes

Key Cases Cited

  • Wyeth v. Kappos, 591 F.3d 1364 (Fed. Cir. 2010) (explaining PTA calculation and statutory framework)
  • Chester v. Miller, 906 F.2d 1574 (Fed. Cir. 1990) (Section 132 satisfied if rejection informs applicant of broad statutory basis so applicant can respond)
  • White v. United States, 543 F.3d 1330 (Fed. Cir. 2008) (plain statutory language ends inquiry)
  • Centech Group v. United States, 554 F.3d 1029 (Fed. Cir. 2009) (APA standard applies to PTO PTA determinations)
  • In re Hughes, 345 F.2d 184 (C.C.P.A. 1965) (applicant must be informed of the broad statutory basis for rejection)
Read the full case

Case Details

Case Name: Pfizer, Inc. v. Lee
Court Name: Court of Appeals for the Federal Circuit
Date Published: Jan 22, 2016
Citation: 811 F.3d 466
Docket Number: 2015-1265
Court Abbreviation: Fed. Cir.